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Abstract
Anti-thyroid peroxidase antibody (TPO-Ab) is revealed to be inversely associated with
thyroid cysts among euthyroid population. TPO-Ab causes autoimmune thyroiditis by bol-
stering thyroid inflammation. Therefore, at least partly, absence of thyroid cysts could
indicate latent thyroid damage. Since participants with subclinical hypothyroidism are
reported to have higher HbA1c than normal healthy controls, HbA1c could be inversely
associated with thyroid cysts through a mechanism reflecting latent thyroid damage. To
investigate the association between HbA1c and thyroid cysts among a euthyroid popula-
tion, a cross-sectional study was conducted on 1,724 Japanese individuals who were
within the normal range of thyroid function [i.e., normal range of free triiodothyronine (T3)
and free thyroxine (T4)] and aged 40–74 years. Among this study population, 564 were
diagnosed with thyroid cysts. Independently of thyroid related hormones [thyroid stimulat-
ing hormone (TSH), free T3, and free T4] and known cardiovascular risk factors, HbA1c
was found to be significantly inversely associated with the presence of thyroid cysts. This
association remained significant even after this analysis was limited to participants within
a normal range of TSH. The fully adjusted odds ratios (ORs) of thyroid cysts for 1 stan-
dard deviation (SD) increment of HbA1c were 0.84 (0.74, 0.95) for total participants and
0.80 (0.70, 0.92) for participants within a normal range of TSH. Among participants with
normal thyroid function, HbA1c was inversely associated with the presence of thyroid
cysts. The absence of thyroid cysts and higher levels of HbA1c could indicate the latent
functional damage of the thyroid.
PLOS ONE







Citation: Shimizu Y, Kawashiri S-Y, Noguchi Y,
Nagata Y, Maeda T, Hayashida N (2021) HbA1c is
inversely associated with thyroid cysts in a
euthyroid population: A cross-sectional study.
PLoS ONE 16(6): e0253841. https://doi.org/
10.1371/journal.pone.0253841
Editor: Silvia Naitza, Consiglio Nazionale delle
Ricerche, ITALY
Received: May 11, 2020
Accepted: June 14, 2021
Published: June 30, 2021
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0253841
Copyright: © 2021 Shimizu et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: We cannot publicly
provide individual data due to participant privacy,
according to ethical guidelines in Japan.
Additionally, the informed consent was obtained
Introduction
The fluid collected from thyroid cysts is reportedly rich in thyroglobulin [1], which contributes
to the synthesis of thyroid hormones such as triiodothyronine (T3) and thyroxine (T4) [2].
We previously identified a significant positive association between thyroid cysts and iso-
lated systolic hypertension among euthyroid participants [3]. Since hyperthyroidism is a
major secondary cause of isolated systolic hypertension [4], euthyroid participants with thy-
roid cysts might have relatively higher thyroid hormone synthesizing activity than those with-
out thyroid cysts.
In addition, our previous study reported an inverse association between anti-thyroid perox-
idase antibody (TPO-Ab) and thyroid cysts among participants with normal thyroid hormone
levels [5]. As TPO-Ab inhibits thyroid peroxidase, which plays an important role in synthesiz-
ing thyroid hormones [6], the absence of thyroid cysts in euthyroid individuals could indicate
latent damage to the thyroid.
Another cross-sectional study reported that the levels of HbA1c in non-diabetic partici-
pants with subclinical hypothyroidism were significantly higher than those in normal healthy
controls [7].
As the absence of thyroid cysts might indicate latent damage to the thyroid [5] and a lower
productivity of thyroid hormone [8] and subclinical hypothyroidism might cause HbA1c ele-
vation [7], HbA1c could be inversely associated with thyroid cysts among participants with
normal thyroid function. However, no study has reported these associations.
To clarify these associations, we conducted a cross-sectional study of 1,724 Japanese indi-
viduals who participated in an annual health check-up in 2014 and who had normal range of
thyroid function (i.e., normal range of free T3 and free T4) and aged 40–74 years.
Materials and methods
Study population
The methods that relate to the present risk surveys, including thyroid function, have also been
described elsewhere [3,5,8].
Written consent forms were made available to ensure that participants understood the
objective of the study, for which informed consent was obtained. This study was approved by
the Ethics Committee of Nagasaki University Graduate School of Biomedical Sciences (project
registration number 14051404).
The study population comprised 1,883 Japanese individuals aged 40–74 years from Saza
town in the western part of Japan who underwent an annual medical check-up in 2014, as rec-
ommended by the Japanese government.
To preclude any influence of thyroid disease, participants with a history of thyroid disease
(n = 60); without thyroid function data such as TSH, free T3, and free T4 (n = 17); and with
abnormal ranges of free T3 (normal range: 2.1–4.1. pg/mL) and free T4 (normal range: 1.0–
1.7. ng/dL) were excluded (n = 77).
Additionally, participants without data on body mass index (BMI) (n = 1), blood pressure
(n = 1), or personal habits (smoking status and drinking status) (n = 3) were excluded.
The remaining participants, comprising 1,724 individuals with a mean age of 60.5 years
[standard deviation (SD): 9.1; range: 40–74 years], were enrolled in the study.
Data collection and laboratory measurements
A trained interviewer obtained information on clinical characteristics, such as history of thy-
roid disease, glucose-lowering medication use, and status of preferences (smoking and
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drinking). Body weight and height were measured using an automatic body composition ana-
lyzer (BF-220; Tanita, Tokyo, Japan), and BMI (kg/m2) was calculated. Systolic blood pressure
(SBP) was recorded at rest.
Fasting blood samples were collected. TSH, free T3, and free T4 levels were measured by
standard procedures at the LSI Medience Corporation (Tokyo, Japan). HbA1c, triglyceride
(TG), and high-density lipoprotein cholesterol (HDLc) levels were also measured using stan-
dard procedures at SRL Inc. (Tokyo, Japan). The threshold for subclinical hypothyroidism is
set at TSH> 4.01 μIU/mL.
The presence or absence of thyroid cysts was determined by experienced technicians using
LOGIQ Book XP with a 10-MHz transducer (GE Healthcare, Milwaukee, WI, USA). A thyroid
cyst was defined to have a maximum diameter of�2.0 mm without a solid component, as indi-
cated in our previous study [3,5,8].
Statistical analysis
Characteristics of the entire study population as well as cohorts divided by HbA1c levels
(<5.6% for [low], 5.6–6.4% for [medium], and 6.5%� for [high]) were expressed as
means ± standard deviations (SDs), except for the categories of male sex, use of glucose-lower-
ing medication, preference history (current smoker and daily drinker), and TSH. These cate-
gories were expressed as percentages. As TSH showed a skewed distribution, it was expressed
as the median [first quartile, third quartile]. Significant differences in HbA1c levels were evalu-
ated using analysis of variance.
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regres-
sion models to assess association between HbA1c and subclinical hypothyroidism.
Simple correlation analysis was performed to evaluate the correlations between HbA1c and
TSH levels and thyroid hormone (free T3 and free T4) levels.
Logistic regression models were also used to calculate ORs and 95% CIs to determine the
association between HbA1c and thyroid cysts.
Three adjustment models were used. The first model was adjusted for sex and age (model
1). The second (model 2) further included the potential confounding factors that were directly
associated with thyroid function, namely free T3 (pg/mL) and TSH (μIU/mL). The last model
(model 3) was further adjusted for potential confounding factors that were indirectly associ-
ated with thyroid function, such as BMI (kg/m2), smoking status (never, former, current),
drinking status (non, often, daily), SBP (mmHg), TG level (mg/dL), and HDLc level (mg/dL).
We also limited those analyses to participants with normal ranges of TSH and those not using
glucose-lowering medication.
All statistical analyses were performed using the SAS system for Windows (version 9.4; SAS
Inc., Cary, NC, USA). Results with p<0.05 were considered statistically significant.
Results
In the study population, 564 (32.7%) were diagnosed to have thyroid cysts.
Characteristics of the study population
Characteristics of the study population are shown in Table 1. Among the 1,724 patients
enrolled, 37.0% were men. Free T3 and free T4 levels in the population were 3.17 ± 0.32 pg/mL
and 1.25 ± 0.16 ng/dL, respectively. The median [the first quartile, the third quartile] levels of
TSH were 1.58 [1.08, 2.29] μIU/mL.
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Characteristics of the study population according to HbA1c levels
Table 2 shows characteristics of the study population based on HbA1c levels. Male gender, age,
TSH, BMI, SBP, use of glucose-lowering medication, and TG were significantly and positively
associated with HbA1c levels.
Association between subclinical hypothyroidism and HbA1c
Table 3 shows a significant positive association between HbA1c and subclinical hypothyroid-
ism that is independent of known cardiovascular risk factors.
Table 1. Characteristics of the study population.
No of participants 1,724
Men, % 37.0
Age, year 60.5 ± 9.1
Free T3, pg/mL 3.17 ± 0.32
Free T4, ng/dL 1.25 ± 0.16
TSH, μIU/mL 1.58 [1.08, 2.29]�1
BMI, kg/m2 22.8 ± 3.4
SBP, mmHg 125 ± 17
Current smoker, % 13.7
Daily drinker, % 40.3
Glucose-lowering medication use, % 6.1
TG, mg/dL 105 ± 74
HDLc, mg/dL 60 ± 15
T3; triiodothyronine, T4; thyroxine, TSH; thyroid stimulating hormone, BMI; body mass index, SBP; systolic blood
pressure, TG; triglyceride, HDLc; high-density lipoprotein cholesterol. Values are means ± standard deviations.
�1: Values are median [the first quartile, the third quartile].
https://doi.org/10.1371/journal.pone.0253841.t001
Table 2. Characteristics of study population according to HbA1c levels.
HbA1c levels
< 5.6% [low] 5.6–6.4% [medium] 6.5%� [high] P
No of participants 985 616 123
Men, % 36.9 34.4 51.2 0.002
Age, year 58.5 ± 9.5 63.0 ± 7.9 64.0 ± 7.2 <0.001
free T3, pg/mL 3.17 ± 0.32 3.18 ± 0.32 3.13 ± 0.34 0.234
free T4, ng/dL 1.25 ± 0.16 1.24 ± 0.16 1.27 ± 0.17 0.400
TSH, μIU/mL 1.54 [1.05, 2.20]�1 1.60 [1.13, 2.39]�1 1.81 [1.20, 2.72]�1 <0.001�2
BMI, kg/m2 22.1 ± 3.1 23.4 ± 3.4 25.0 ± 3.9 <0.001
SBP, mmHg 122 ± 16 127 ± 17 131 ± 18 <0.001
Current smoker, % 14.9 10.6 19.5 0.069
Daily drinker, % 43.4 35.7 38.2 0.008
Glucose-lowering medication use, % 0.2 5.2 57.2 <0.001
TG, mg/dL 97 ± 65 113 ± 78 138 ± 98 <0.001
HDLc, mg/dL 62 ± 15 59 ± 14 54 ± 15 <0.001
T3; triiodothyronine, T4; thyroxine, TSH; thyroid stimulating hormone, BMI; body mass index, SBP; systolic blood pressure, TG; triglycerides, HDLc; high-density
lipoprotein cholesterol. Values are mean ±standard deviation.
�1: Values are median [the first quartile, the third quartile]. Regression model for mean values was used for determining p values.
�2: Logarithmic transformation was used for evaluating p.
https://doi.org/10.1371/journal.pone.0253841.t002
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Correlation among HbA1c, TSH, and thyroid hormone
Table 4 shows the correlation among HbA1c, TSH, and thyroid hormone levels. HbA1c was
significantly and positively correlated with TSH level in all participants but not in those
within normal TSH range. For both groups, thyroid hormones (free T3 and free T4) showed
no significant association with HbA1c level but were significantly inversely associated with
TSH level.
Association between thyroid cysts and HbA1c levels in all participants and
in those within normal TSH range
Table 5 shows the association between thyroid cysts and HbA1c levels for all participants and
those within the normal range of TSH. HbA1c level was significantly inversely associated with
thyroid cysts for both total participants and those within the normal range of TSH. These asso-
ciations remained significant even after further adjustment for thyroid function and known
cardiovascular risk factors.
Association between thyroid cysts and HbA1c levels among participants
not receiving glucose-lowering medication
As glucose-lowering medications might have influenced our study results, we also conducted
an analysis limited to participants not receiving such medications, as shown in Table 6.
Table 3. Odds ratios (ORs) and 95% confidence intervals (CIs) of subclinical hypothyroidism in relation to HbA1c levels.
HbA1c levels p 1 SD increment of HbA1c
< 5.6% [low] 5.6–6.4% [medium] 6.5%� [high]
No of participants 985 616 123
No. of case (%) 36 (3.7) 43 (7.0) 19 (15.4)
Model 1 1 1.98 (1.24, 3.16) 2.39 (1.34, 4.29) <0.001 1.44 (1.35, 1.66)
Model 2 1 2.01 (1.26, 3.21) 2.27 (1.26, 4.09) <0.001 1.43 (1.19, 1.71)
Model 3 1 1.74 (1.08, 2.82) 2.03 (1.12, 3.69) 0.003 1.35 (1.16, 1.58)
Case: Participants with subclinical hypothyroidism. Model 1: Adjusted for sex and age. Model 2: + free T3 and TSH. Model 3: + BMI, smoking status (never, former,
current), drinking status (non, often, daily), SBP, TG and HDLc. 1 standard deviation (SD) increment of HbA1c was 0.7% for men and 0.6% for women.
https://doi.org/10.1371/journal.pone.0253841.t003
Table 4. Correlation among HbA1c, thyroid stimulating hormone (TSH) and thyroid hormones (free T3 and free
T4) levels.
TSH Triiodothyronine (free T3) Thyroxine (free T4)
r (p) R (p) r (p)
Total
No of participants 1724
HbA1c 0.11 <0.001 -0.04 0.074 0.01 0.605
TSH - - -0.12 <0.001 -0.15 <0.001
Normal TSH
No of participants 1598
HbA1c 0.05 0.069 -0.03 0.217 0.04 0.143
TSH - - -0.10 <0.001 -0.08 <0.001
r: Simple correlation coefficient.
https://doi.org/10.1371/journal.pone.0253841.t004
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Essentially, the same associations were noted for both total participants and participants with
normal TSH range.
Sex-specific analysis among participants with in normal range of TSH and
not receiving glucose-lowering medication
For sensitivity analysis, we also performed sex-specific analysis among participants not receiv-
ing glucose-lowering medication and found essentially the same associations. Fully adjusted
ORs and 95%CIs of thyroid cysts for 1 SD increment of HbA1c were 0.87 (0.66, 1.16) for men
(n [euthyroid individuals] = 536, cases [thyroid cysts] = 139) and 0.74 (0.59, 0.99) for women
(n = 971, cases = 361), respectively.
Table 5. Odds ratios (ORs) and 95% confidence intervals (CIs) of thyroid cyst in relation to HbA1c levels.
HbA1c levels p 1 SD increment of HbA1c
< 5.6% [low] 5.6–6.4% [medium] 6.5%� [high]
Total
No of participants 985 616 123
No. of case (%) 320 (32.5) 216 (35.1) 28 (22.8)
Model 1 1 0.95 (0.76, 1.19) 0.57 (0.36, 0.91) 0.041 0.83 (0.74, 0.94)
Model 2 1 0.96 (0.77, 1.20) 0.57 (0.36, 0.91) 0.046 0.83 (0.74, 0.94)
Model 3 1 0.97 (0.77, 1.22) 0.58 (0.36, 0.92) 0.075 0.84 (0.74, 0.95)
Normal range of TSH
No of participants 930 565 103
No. of case (%) 303 (32.6) 202 (35.8) 21 (20.4)
Model 1 1 0.97 (0.77, 1.22) 0.48 (0.29, 0.80) 0.035 0.80 (0.71, 0.92)
Model 2 1 0.97 (0.77, 1.23) 0.48 (0.28, 0.80) 0.035 0.80 (0.71, 0.92)
Model 3 1 0.98 (0.77, 1.23) 0.48 (0.28, 0.81) 0.045 0.80 (0.70, 0.92)
Case: Participants with thyroid cysts. Model 1: Adjusted for sex and age. Model 2: + free T3 and TSH. Model 3: + BMI, smoking status (never, former, current), drinking
status (non, often, daily), SBP, TG and HDLc. 1 standard deviation (SD) increment of HbA1c were 0.7% for men and 0.6% for women.
https://doi.org/10.1371/journal.pone.0253841.t005
Table 6. Odds ratios (ORs) and 95% confidence intervals (CIs) of thyroid cyst in relation to HbA1c levels limited to participants not receiving glucose-lowering
medication.
HbA1c levels p 1 SD increment of HbA1c
< 5.6% [low] 5.6–6.4% [medium] 6.5%� [high]
Total
No of participants 983 584 52
No. of case (%) 319 (32.5) 205 (35.1) 10 (19.2)
Model 1 1 0.96 (0.72, 1.20) 0.46 (0.23, 0.95) 0.146 0.83 (0.71, 0.97)
Model 2 1 0.97 (0.77, 1.21) 0.46 (0.23, 0.95) 0.161 0.84 (0.71, 0.98)
Model 3 1 0.98 (0.78, 1.23) 0.48 (0.23, 1.00) 0.249 0.85 (0.71, 0.997)
Normal range of TSH
No of participants 928 535 44
No. of case (%) 302 (32.5) 191 (35.7) 7 (15.9)
Model 1 1 0.98 (0.77, 1.23) 0.36 (0.16, 0.84) 0.148 0.79 (0.67, 0.94)
Model 2 1 0.98 (0.72, 1.23) 0.36 (0.16, 0.84) 0.151 0.79 (0.67, 0.94)
Model 3 1 0.99 (0.78, 1.25) 0.38 (0.16, 0.88) 0.222 0.80 (0.67, 0.95)
Case: Participants with thyroid cysts. Model 1: Adjusted for sex and age. Model 2: + free T3 and TSH. Model 3: + BMI, smoking status (never, former, current), drinking
status (non, often, daily), SBP, TG and HDLc. 1 standard deviation (SD) increment of HbA1c were 0.7% for men and 0.6% for women.
https://doi.org/10.1371/journal.pone.0253841.t006
PLOS ONE HbA1c and thyroid cysts
PLOS ONE | https://doi.org/10.1371/journal.pone.0253841 June 30, 2021 6 / 10
Discussion
The major findings of the present study are that, independent of thyroid function, HbA1c is
significantly inversely associated with thyroid cysts in the euthyroid population. This signifi-
cant association remained even after the analyses were limited to participants with a normal
range of TSH.
The absence of thyroid cysts might indicate latent damage to the thyroid, as a previous
study on a euthyroid population revealed an independent inverse association between thyroid
cysts and TPO-Ab, which is a known cause of autoimmune thyroiditis [5].
A high prevalence of TPO-Ab (+) has been reported in subclinical hypothyroidism [9,10],
and hypothyroidism is known to be associated with hypertension [11]. Our previous study
also revealed a positive association between subclinical hypothyroidism and hypertension
among participants without thyroid cysts but not among participants with thyroid cysts [3].
Thus, the absence of thyroid cysts might have a disadvantage in the production of thyroid hor-
mones, possibly by indicating latent damage of the thyroid.
In the present study, we found further evidence that HbA1c was significantly inversely asso-
ciated with thyroid cysts in the euthyroid population (Tables 5 and 6).
Both hyperthyroidism and hypothyroidism are reported to be associated with the develop-
ment of insulin resistance [12]. However, a positive linear association between the normal
range of TSH level and insulin resistance among non-diabetes participants and type 2 diabetes
patients has been reported [13]. Furthermore, a positive correlation between HbA1c and TSH
levels was also observed in patients with subclinical hypothyroidism [14].
Hypothyroidism can break the equilibrium between thyroid hormone and glucose homeo-
stasis and alter glucose metabolism, which can lead to insulin resistance [15]. Insulin resistance
elevates HbA1c levels, and higher HbA1c levels could be associated with lower thyroid hor-
mone activity, partly by indicating latent damage to the thyroid. Generally, levels of TSH that
are high but within the normal range of thyroid hormones (free T3 and free T4) are considered
to indicate subclinical hypothyroidism.
In the present study, we found a significant positive association between subclinical hypo-
thyroidism and HbA1c (Table 3). This is consistent with the findings of a previous study that
reported the levels of HbA1c in non-diabetic participants with subclinical hypothyroidism to
be higher than those in normal healthy controls [7].
As the absence of thyroid cysts might indicate latent damage to the thyroid [3,5,8], insulin
resistance related to TSH levels might underlie the association between thyroid cysts and HbA1c.
In fact, in our additional analysis, a slight but significant positive association between TSH and
HbA1c levels was observed, while significant inverse associations between TSH and thyroid hor-
mone (free T3 and free T4) levels were observed among all euthyroid participants (Table 4).
However, the magnitude of the observed associations (between TSH and HbA1c, and
between TSH and thyroid hormones) were too small to explain the present results showing a
significant inverse association between HbA1c and thyroid cysts. The magnitude of physiolog-
ical demand for thyroid hormone activity might explain this discrepancy. Because decreased
thyroid function may extend longevity, the demand for thyroid hormone activity may decrease
with age [16]. Therefore, not only the serum thyroid hormone level, but also the demand for
thyroid activity might determine the level of TSH secretion. HbA1c levels may indicate the
magnitude of thyroid hormone deficiency in the same way that the equilibrium between thy-
roid hormone and glucose might determine insulin resistance [15]. In the present study,
HbA1c was significantly positively correlated with subclinical hypothyroidism (Table 3) but
not with thyroid hormone (Table 4). Because the absence of thyroid cysts indicates latent dam-
age to the thyroid [3,5,8], HbA1c levels could inversely associate with thyroid cysts (Table 5).
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The same associations between HbA1c levels and thyroid cysts were observed when analy-
ses were limited to the normal TSH range (Table 5).
Therefore, the absence of thyroid cysts and higher levels of HbA1c could indicate the latent
functional damage of the thyroid.
Because the same glucose-lowering medication could influence thyroid function [17],
which could influence the main results of our study, we conducted further analyses limited to
participants who were not receiving glucose-lowering medications. A significant inverse asso-
ciation between HbA1c levels and thyroid cysts was observed even in the analyses that were
limited to participants not receiving glucose-lowering medications (Table 6). Therefore, glu-
cose-lowering medications that influence HbA1c levels could not explain the present main
findings. Further investigation that directly indicates insulin resistance, such as HOMA-IR, is
necessary.
Insulin resistance is known to be associated with thyroid function [12,13]. Thus, the present
finding showing an inverse association between HbA1c level and thyroid cysts among partici-
pants with completely normal thyroid function (normal range of TSH and thyroid hormones
such as free T3 and free T4) could indicate that thyroid cysts act as an indicator of thyroid
activity, which could not be evaluated based on TSH, free T3, and free T4 levels. Therefore, the
present study provides new insights for evaluating thyroid function in general clinical practice,
although thyroid cysts are considered to lack significance in general. Furthermore, the impor-
tance of HbA1c level control in patients with subclinical hypothyroidism has been emphasized
in a previous study [14]. Present findings could provide efficient cues to control HbA1c associ-
ated with the latent functional damage of the thyroid.
The potential limitations of this study warrant consideration. First, we evaluated the exis-
tence of thyroid cysts solely by their presence or absence. However, the volumes and number
of cysts might also influence the present results, and further investigations using these data are
necessary. Second, this was a cross-sectional study, and causal relationships could not be estab-
lished. Third, the turnover of thyroid hormone may be influenced by status of thyroid cysts,
but we could not evaluate the half-life of thyroid hormone.
Conclusion
In conclusion, among participants with normal thyroid function, HbA1c level was found to be
inversely associated with the presence of thyroid cysts. Although further investigations on the
present topic are necessary, the absence of thyroid cysts and higher levels of HbA1c could indi-
cate the latent functional damage of the thyroid.
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